Learn about the best path towards clinical data acquisition in the payer market.
With large volumes of clinical data supporting a range of workflows including prior auth, quality reporting, risk adjustment, and care management, there’s an increased need for payers to move to clinical data acquisition workflows that are scalable, organized, timely, efficient and standards-based.
In this evolving landscape, our speakers, Alison Aluli-Imberman, Vice President of Operations at Health First Health Plans, Don Rucker, Chief Strategy Officer at 1upHealth, are guided by the expertise of panel moderator Miriam Paramore, a Health Information Technology Expert. They discuss the challenges and the best path forward towards clinical data acquisition that’s not only efficient but also standards-driven, bringing a new level of scalability to the payer market.
Speakers
Miriam Paramore
Healthcare & Health Information Technology Expert
Miriam Paramore has been influencing the direction of the healthcare technology industry for more than 30 years. Her contributions have had a significant impact on the major healthcare business sectors – providers, payers, pharma, and, most importantly, patients. It has been Miriam’s life’s work to improve the U.S. healthcare system through the power of information. She is an expert in healthcare IT as well as healthcare data and the rules that govern it.
Alison Aluli-Imberman
Vice President of Operations, Health First Health Plan
Dr. Don Rucker
Chief Strategy Officer
Dr. Donald Rucker is the Chief Strategy Officer of 1upHealth. As National Coordinator of Health IT at The US Department of Health and Human Services (HHS) from 2017 to 2021, Dr. Rucker led the writing of the Office of the National Coordinator for Health Information Technology’s (ONC) 21st Century Cures Act Interoperability Rule, which enabled the modern healthcare app economy by requiring EHRs to have standardized FHIR APIs and provided patients with secure actionable electronic access to their data by implementing the Congressional prohibition of “information blocking.”